English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [843]
News [2101]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
How can a systems biology approach aid precision cancer medicine?
Dr Andrea Califano, Columbia University Department of Systems Biology, New York...
How can a systems biology approach aid precision cancer medicine? ( Dr Andrea Califano, Columbia University Department of Systems Biology, New York, USA )
6 Jul 2015
Personalised, genomic-guided combination therapy could transform early disease...
Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA
Personalised, genomic-guided combination therapy could transform early disease management in ovarian and breast cancer ( Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA )
6 Jul 2015
What can T-cells see on human cancer?
Prof Ton Schumacher – The Netherlands Cancer Institute, Amsterdam, The...
What can T-cells see on human cancer? ( Prof Ton Schumacher – The Netherlands Cancer Institute, Amsterdam, The Netherlands )
6 Jul 2015
Moving precision medicine for lung cancer into the adjuvant setting
Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA
Moving precision medicine for lung cancer into the adjuvant setting ( Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jul 2015
The importance of target expression in personalised medicine
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
The importance of target expression in personalised medicine ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jul 2015
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL...
Dr Paula Cramer - University of Cologne, Köln, Germany
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )
30 Jun 2015
TAT 2016: Targeted anticancer therapies
Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
19 Jun 2015
EHA 2015 highlights
Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid...
Prof Susan Branford - Adelaide University Adelaide, Australia
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ( Prof Susan Branford - Adelaide University Adelaide, Australia )
13 Jun 2015
DNMT3A R882 mutations promote chemoresistance and residual disease in AML
Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
DNMT3A R882 mutations promote chemoresistance and residual disease in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
12 Jun 2015
Expert overview on the recent developments in mantle cell lymphoma
Professor Gordon McVie and Professor Simon Rule
Expert overview on the recent developments in mantle cell lymphoma ( Professor Gordon McVie and Professor Simon Rule )
12 Jun 2015
Round-up of the latest research on lung cancer
Dr James Spicer - Guy's Hospital, London, UK
Round-up of the latest research on lung cancer ( Dr James Spicer - Guy's Hospital, London, UK )
9 Jun 2015
<1...5960616263...71>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top